1. Overview

Light therapy leverages the therapeutic effects of red (600–700 nm) and near-infrared (NIR, 700–1100 nm) photonic energy. Unlike photodynamic therapy (which requires photosensitizers) or UV phototherapy (used primarily for dermatological conditions like psoriasis), PBM relies on endogenous chromophores—primarily cytochrome c oxidase in mitochondria—to modulate cellular signaling pathways.1

Clinical applications span dermatology, pain management, neurology, sports medicine, and psychiatry (particularly seasonal affective disorder). Protocol efficacy depends on precise parameter selection, as PBM exhibits a biphasic dose-response curve (Arndt-Schulz law), where both under-dosing and over-dosing reduce therapeutic outcomes.2

2. Mechanisms of Action

The primary mechanism involves photon absorption by cytochrome c oxidase, which increases mitochondrial membrane potential, ATP production, and transient reactive oxygen species (ROS) signaling. This cascade modulates transcription factors (NF-κB, Nrf2, HIF-1α), reducing pro-inflammatory cytokines while upregulating growth factors (VEGF, FGF, BDNF).3

  • Red light (630–670 nm): Penetrates superficially (2–5 mm), ideal for skin, mucosa, and wound healing.
  • Near-infrared (800–850 nm): Penetrates deeper (3–10 cm), targeting muscle, joint, and neural tissue.
  • Blue light (400–470 nm): Antimicrobial and circadian-regulating; used for acne and SAD.

3. Clinical Protocols

đź©ą Wound Healing & Dermatological Repair

Applied to chronic ulcers, surgical wounds, and post-procedure recovery to accelerate epithelialization and reduce scarring.

Wavelength630–660 nm (Red)
Irradiance30–50 mW/cm²
Fluence4–10 J/cm²
FrequencyDaily–Every 48h

🦵 Musculoskeletal Pain & Inflammation

Used for osteoarthritis, tendinopathy, and delayed-onset muscle soreness (DOMS). Combines red and NIR for deep tissue modulation.

Wavelength660 nm + 810–850 nm
Irradiance50–100 mW/cm²
Fluence10–20 J/cm²
Frequency3–5×/week

🧠 Neurological & Psychiatric (SAD/Depression)

Full-spectrum bright light (10,000 lux) administered via light boxes for circadian realignment and mood regulation.

Intensity10,000 lux
Distance30–50 cm from eyes
Duration20–30 min
TimingMorning (within 1h of waking)

4. Dosing & Parameters

Optimal PBM dosing follows the two-hit model and wavelength-specific penetration depths. Parameters must be individualized based on tissue depth, pathology, and device output verification.

Parameter Typical Range Clinical Consideration
Wavelength 600–1100 nm Peaks at 630, 660, 810, 830, 880 nm for chromophore absorption
Irradiance 10–200 mW/cm² Higher irradiance requires shorter exposure to maintain fluence
Fluence (Dose) 1–20 J/cm² Biphasic response; 4–15 J/cm² most common for PBM
Pulse vs Continuous Continuous preferred Pulsed modes (10–100 Hz) show mixed evidence
⚠️ Dosing Warning Exceeding the inhibitory threshold (>20–40 J/cm² depending on tissue) can suppress cellular responses. Always verify device output with a radiometer before clinical application.4

5. Safety & Contraindications

PBM is classified as a Class I or II laser/LED device, making it non-ionizing and generally safe. However, clinical contraindications and precautions exist:

  • Absolutely contraindicated: Direct irradiation of the thyroid gland, malignant tumors (theoretical risk of stimulating angiogenesis), and during active hemorrhage.
  • Relative contraindications: Photosensitizing medications (tetracyclines, amiodarone), pregnancy (abdominal/pelvic application), and epilepsy (fluctuating light patterns).
  • Eye safety: NIR light can bypass ocular filters; use ANSI Z136.1 compliant protective eyewear when irradiating near the head/face.

Common side effects are rare but may include temporary mild headache, fatigue, or transient erythema at high fluences. No systemic toxicity or thermal damage occurs within therapeutic parameters.5

References

  1. Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-361.
  2. Hamblin MR. Shining a light on biophotonics: Photobiomodulation. WIREs Nanomed Nanobiotechnol. 2019;11(5):e1556.
  3. Caruso F, et al. Photobiomodulation in dermatology: A systematic review. Int J Mol Sci. 2022;23(4):2031.
  4. Ahmed M, et al. Biphasic dose responses in photobiomodulation. Photomed Laser Surg. 2020;38(6):255-262.
  5. ANSI Z136.1-2022: Safe Use of Lasers. American National Standards Institute, 2022.
  6. Randall A, et al. Guidelines for clinical laser therapy. Lasers Med Sci. 2023;38:42.